Bangrui Biotech - May 2026 Revenue Reaches NT$300.38 Million (YoY +12.6%)
NQ Score
76/100
N1 Content Completeness
85
AI Summary (NQ-processed)
Bangrui Biotech (stock code: 6955), a biotechnology and healthcare company based in Taiwan, announced its May 2026 revenue of NT$300.38 million, representing a 12.6% year-on-year increase.
AI Analysis
Frequently Asked Questions
- Q: What was Bangrui Biotech's revenue in May 2026?
- A: NT$300.38 million, a 12.6% increase year-on-year.
- Q: What industry is the company in?
- A: Biotechnology and healthcare, focusing on R&D of medical technologies.
- Q: What drove the growth?
- A: Not disclosed, but likely due to increased demand and new contracts.